281 related articles for article (PubMed ID: 21083328)
1. A novel LC-MS approach for the detection of metabolites in DMPK studies.
Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
[TBL] [Abstract][Full Text] [Related]
2. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography.
Kertesz V; Van Berkel GJ; Vavrek M; Koeplinger KA; Schneider BB; Covey TR
Anal Chem; 2008 Jul; 80(13):5168-77. PubMed ID: 18481874
[TBL] [Abstract][Full Text] [Related]
3. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
Jian W; Edom RW; Xu Y; Gallagher J; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
[TBL] [Abstract][Full Text] [Related]
4. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
Ma S; Zhu M
Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
[TBL] [Abstract][Full Text] [Related]
6. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
Furlong M; Bessire A; Song W; Huntington C; Groeber E
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
Hsieh Y
Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective quantification of chiral drugs in human plasma with LC-MS/MS.
Liu K; Zhong D; Chen X
Bioanalysis; 2009 Jun; 1(3):561-76. PubMed ID: 21083153
[TBL] [Abstract][Full Text] [Related]
9. Identifying and overcoming bioanalytical challenges associated with chlorine-containing dehydrogenation metabolites.
Furlong MT; Wujcik CE; Ji C; Su Y
Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3092-102. PubMed ID: 20941755
[TBL] [Abstract][Full Text] [Related]
10. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
Hsieh Y
J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
[TBL] [Abstract][Full Text] [Related]
11. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.
Xie C; Zhong D; Yu K; Chen X
Bioanalysis; 2012 May; 4(8):937-59. PubMed ID: 22533568
[TBL] [Abstract][Full Text] [Related]
13. Chemical derivatization as a tool for optimizing MS response in sensitive LC-MS/MS bioanalysis and its role in pharmacokinetic studies.
Niwa M
Bioanalysis; 2012 Jan; 4(2):213-20. PubMed ID: 22250803
[TBL] [Abstract][Full Text] [Related]
14. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
[TBL] [Abstract][Full Text] [Related]
15. Automated liquid microjunction surface sampling-HPLC-MS/MS analysis of drugs and metabolites in whole-body thin tissue sections.
Kertesz V; Van Berkel GJ
Bioanalysis; 2013 Apr; 5(7):819-26. PubMed ID: 23534426
[TBL] [Abstract][Full Text] [Related]
16. Rapid analysis of isomeric exogenous metabolites by differential mobility spectrometry-mass spectrometry.
Parson WB; Schneider BB; Kertesz V; Corr JJ; Covey TR; Van Berkel GJ
Rapid Commun Mass Spectrom; 2011 Nov; 25(22):3382-6. PubMed ID: 22002690
[TBL] [Abstract][Full Text] [Related]
17. In vitro formation of phase I and II metabolites of propranolol and determination of their structures using chemical derivatization and liquid chromatography-tandem mass spectrometry.
Lampinen Salomonsson M; Bondesson U; Hedeland M
J Mass Spectrom; 2009 May; 44(5):742-54. PubMed ID: 19170146
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
19. Minimizing matrix effects while preserving throughput in LC-MS/MS bioanalysis.
Ye Z; Tsao H; Gao H; Brummel CL
Bioanalysis; 2011 Jul; 3(14):1587-601. PubMed ID: 21756092
[TBL] [Abstract][Full Text] [Related]
20. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
Nassar AE; Adams PE
Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
